Course fees and academic ranking: Insights from the IMI EMTRAIN on-course® database

Antony Payton; Pavel Dallakian; Alexander Fitton; Anna Payton; Mike Hardman; Martin Yuille; Tony Payton

doi:10.1016/j.drudis.2013.12.001

Course fees and academic ranking: Insights from the IMI EMTRAIN on-course® database

Antony Payton, Pavel Dallakian, Alexander Fitton, Anna Payton, Mike Hardman, Martin Yuille, Tony Payton (Collaborator)

Research output: Contribution to journal › Article › peer-review

Abstract

The Innovative Medicines Initiative (IMI) funded project on-course ® (http://www.on-course.eu/) lists postgraduate biomedical courses in Europe and is comprehensive for all taught and research master's courses. Using on-course®, new insights into education and training in Europe can be delivered; and here we investigate the relationship between master's course fees and university ranking. We hypothesise that higher master's course fees would be associated with higher university ranking. This was indeed the case for research master's courses and for taught master's courses for non-EU students. However, we observed no correlation between taught master's course fees for EU students and university ranking, meaning EU students are paying on average as much for courses at lower ranked universities as they are for courses at higher ranked universities. © 2014 Published by Elsevier Ltd. All rights reserved.

Original language	English
Pages (from-to)	830-833
Number of pages	3
Journal	Drug discovery today
Volume	19
Issue number	7
Early online date	8 Dec 2013
DOIs	https://doi.org/10.1016/j.drudis.2013.12.001
Publication status	Published - 2014

Access to Document

10.1016/j.drudis.2013.12.001

http://www.elsevier.com/locate/drugdiscov

Cite this

@article{bb5e8772ec954717bc897cbb4296be75,

title = "Course fees and academic ranking: Insights from the IMI EMTRAIN on-course{\textregistered} database",

abstract = "The Innovative Medicines Initiative (IMI) funded project on-course {\textregistered} (http://www.on-course.eu/) lists postgraduate biomedical courses in Europe and is comprehensive for all taught and research master's courses. Using on-course{\textregistered}, new insights into education and training in Europe can be delivered; and here we investigate the relationship between master's course fees and university ranking. We hypothesise that higher master's course fees would be associated with higher university ranking. This was indeed the case for research master's courses and for taught master's courses for non-EU students. However, we observed no correlation between taught master's course fees for EU students and university ranking, meaning EU students are paying on average as much for courses at lower ranked universities as they are for courses at higher ranked universities. {\textcopyright} 2014 Published by Elsevier Ltd. All rights reserved.",

author = "Antony Payton and Pavel Dallakian and Alexander Fitton and Anna Payton and Mike Hardman and Martin Yuille and Tony Payton",

year = "2014",

doi = "10.1016/j.drudis.2013.12.001",

language = "English",

volume = "19",

pages = "830--833",

journal = "Drug discovery today",

issn = "1359-6446",

publisher = "Elsevier BV",

number = "7",

}

TY - JOUR

T1 - Course fees and academic ranking: Insights from the IMI EMTRAIN on-course® database

AU - Payton, Antony

AU - Dallakian, Pavel

AU - Fitton, Alexander

AU - Payton, Anna

AU - Hardman, Mike

AU - Yuille, Martin

A2 - Payton, Tony

PY - 2014

Y1 - 2014

N2 - The Innovative Medicines Initiative (IMI) funded project on-course ® (http://www.on-course.eu/) lists postgraduate biomedical courses in Europe and is comprehensive for all taught and research master's courses. Using on-course®, new insights into education and training in Europe can be delivered; and here we investigate the relationship between master's course fees and university ranking. We hypothesise that higher master's course fees would be associated with higher university ranking. This was indeed the case for research master's courses and for taught master's courses for non-EU students. However, we observed no correlation between taught master's course fees for EU students and university ranking, meaning EU students are paying on average as much for courses at lower ranked universities as they are for courses at higher ranked universities. © 2014 Published by Elsevier Ltd. All rights reserved.

AB - The Innovative Medicines Initiative (IMI) funded project on-course ® (http://www.on-course.eu/) lists postgraduate biomedical courses in Europe and is comprehensive for all taught and research master's courses. Using on-course®, new insights into education and training in Europe can be delivered; and here we investigate the relationship between master's course fees and university ranking. We hypothesise that higher master's course fees would be associated with higher university ranking. This was indeed the case for research master's courses and for taught master's courses for non-EU students. However, we observed no correlation between taught master's course fees for EU students and university ranking, meaning EU students are paying on average as much for courses at lower ranked universities as they are for courses at higher ranked universities. © 2014 Published by Elsevier Ltd. All rights reserved.

U2 - 10.1016/j.drudis.2013.12.001

DO - 10.1016/j.drudis.2013.12.001

M3 - Article

SN - 1359-6446

VL - 19

SP - 830

EP - 833

JO - Drug discovery today

JF - Drug discovery today

IS - 7

ER -

Course fees and academic ranking: Insights from the IMI EMTRAIN on-course® database

Abstract

Access to Document

Fingerprint

Cite this